Budapest, Hungary

Attila Bielik

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Gedeon Richter Vegyeszeti Gyar Rt. Active years: 2008.

USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Attila Bielik: Innovator in Pharmaceutical Chemistry

Introduction

Attila Bielik is a notable inventor based in Budapest, Hungary, recognized for his significant contributions to the field of pharmaceutical chemistry. With a focus on developing novel compounds, he has made strides in the realm of drug discovery.

Latest Patents

Attila holds one patent for his innovative work on Piperidine derivatives as NMDA receptor antagonists. This patent includes a compound of formula (I), wherein specific groups such as V and U encompass hydrogen, halogen, C-Calkylamino, or together form a group containing one or more heteroatoms. His research has potential implications in treating various neurological disorders.

Career Highlights

Attila Bielik is associated with Gedeon Richter Vegyeszeti Gyar Rt, a leading pharmaceutical company. His role there allows him to collaborate on critical projects aimed at advancing therapeutic options in the medical industry. His expertise in medicinal chemistry has been instrumental in aligning the company's research initiatives with innovative drug development.

Collaborations

Throughout his career, Attila has worked alongside talented colleagues such as Gyorgy Domány and Csilla Horváth. These collaborations have enriched his projects, allowing for diverse insights and enhancing the quality of research outcomes. Together, they contribute to a research environment that fosters innovation and advancement.

Conclusion

Attila Bielik stands out as an inventive force in the pharmaceutical sector, with a patent that demonstrates his dedication to enhancing therapeutic measures. His work in collaboration with esteemed colleagues further signifies a commitment to scientific advancement, positioning him as a key player in the future of drug development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…